Samir C. Patel's most recent trade in Kalaris Therapeutics Inc. was a trade of 18,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kalaris Therapeutics Inc. | Samir C. Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) |